The impact of the rare disease and Orphan Drug Act in Taiwan.

Hsiang, Ning-Chun; Huang, Weng-Foung; Gau, Churn-Shiouh; Tsai, Teng-Wen; Chang, Lin-Chau

Hsiang, Ning-Chun; Huang, Weng-Foung; Gau, Churn-Shiouh; Tsai, Teng-Wen; Chang, Lin-Chau.

Afiliação

Hsiang NC; School of Pharmacy, College of Medicine, National Taiwan University, 33 Linsen S. Rd., Zhongzheng Dist., Taipei City, 10050, Taiwan.
Huang WF; Institute of Health and Welfare Policy, National Yang Ming Chiao Tung University, 155, Sec. 2, Linong Street, Beitou Dist., Taipei City, 11221, Taiwan.
Gau CS; School of Pharmacy, College of Medicine, National Taiwan University, 33 Linsen S. Rd., Zhongzheng Dist., Taipei City, 10050, Taiwan.
Tsai TW; School of Pharmacy, College of Medicine, National Taiwan University, 33 Linsen S. Rd., Zhongzheng Dist., Taipei City, 10050, Taiwan.
Chang LC; School of Pharmacy, College of Medicine, National Taiwan University, 33 Linsen S. Rd., Zhongzheng Dist., Taipei City, 10050, Taiwan.

J Food Drug Anal ; 29(4): 717-725, 2021 12 15.

Article em En | MEDLINE | ID: mdl-35649145

Assuntos

Produção de Droga sem Interesse Comercial; Doenças Raras; Governo; Humanos; Doenças Raras/tratamento farmacológico; Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produção de Droga sem Interesse Comercial / Doenças Raras Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google